Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Total Current Liabilities data on record, last reported at $369.7 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 25.09% year-over-year to $369.7 million; the TTM value through Dec 2025 reached $369.7 million, up 25.09%, while the annual FY2025 figure was $369.7 million, 25.09% up from the prior year.
  • Total Current Liabilities reached $369.7 million in Q4 2025 per CLBT's latest filing, up from $295.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $369.7 million in Q4 2025 and bottomed at $186.6 million in Q4 2021.
  • Average Total Current Liabilities over 5 years is $262.7 million, with a median of $253.8 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: increased 11.36% in 2022, then increased 25.09% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $186.6 million in 2021, then grew by 11.36% to $207.8 million in 2022, then grew by 22.16% to $253.8 million in 2023, then grew by 16.42% to $295.5 million in 2024, then grew by 25.09% to $369.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $369.7 million in Q4 2025, $295.5 million in Q4 2024, and $253.8 million in Q4 2023.